Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

被引：0

作者：

Mathew Vithayathil

Antonio D’Alessio

Claudia Angela Maria Fulgenzi

Naoshi Nishida

Martin Schönlein

Johann von Felden

Kornelius Schulze

Henning Wege

Anwaar Saeed

Brooke Wietharn

Hannah Hildebrand

Linda Wu

Celina Ang

Thomas U. Marron

Arndt Weinmann

Peter R. Galle

Dominik Bettinger

Bertram Bengsch

Arndt Vogel

Lorenz Balcar

Bernhard Scheiner

Pei-Chang Lee

Yi-Hsiang Huang

Suneetha Amara

Mahvish Muzaffar

Abdul Rafeh Naqash

Antonella Cammarota

Valentina Zanuso

Tiziana Pressiani

Matthias Pinter

Alessio Cortellini

Masatoshi Kudo

Lorenza Rimassa

David J. Pinato

Rohini Sharma

机构：

[1] Imperial College London,Department of Surgery & Cancer

[2] Hammersmith Campus,Department of Biomedical Sciences

[3] Humanitas University,Division of Medical Oncology

[4] Policlinico Universitario Campus Bio-Medico,Department of Gastroenterology and Hepatology, Faculty of Medicine

[5] Kindai University,Department of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology

[6] University Medical Center Hamburg-Eppendorf,Department of Gastroenterology and Hepatology

[7] University Medical Center Hamburg-Eppendorf,Division of Medical Oncology, Department of Medicine

[8] Kansas University Cancer Center,Division of Hematology/Oncology, Department of Medicine

[9] Tisch Cancer Institute,I. Medical Department

[10] Mount Sinai Hospital,Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Faculty of Medicine

[11] University Medical Center Mainz,Division of Gastroenterology & Hepatology, Department of Internal Medicine III

[12] Freiburg University Medical Center,Division of Gastroenterology and Hepatology, Department of Medicine

[13] University of Freiburg,Institute of Clinical Medicine, School of Medicine

[14] University of Freiburg,Division of Hematology/Oncology

[15] Signalling Research Centers BIOSS and CIBSS,Medical Oncology and Hematology Unit

[16] German Cancer Consortium (DKTK),Division of Oncology, Department of Translational Medicine

[17] Hannover Medical School,undefined

[18] Medical University of Vienna,undefined

[19] Taipei Veterans General Hospital,undefined

[20] National Yang Ming Chiao Tung University,undefined

[21] East Carolina University,undefined

[22] Medical Oncology/TSET Phase 1 Program,undefined

[23] Stephenson Cancer Center,undefined

[24] University of Oklahoma,undefined

[25] Humanitas Cancer Center,undefined

[26] IRCCS Humanitas Research Hospital,undefined

[27] University of Piemonte Orientale,undefined

来源：

Hepatology International | 2023年 / 17卷

关键词：

Immunotherapy; Anti-programmed death-ligand; Anti-vascular endothelial growth factor; Checkpoint inhibitor; Obesity; Cirrhosis; Overall survival; Progression-free survival; Overweight; Non-alcoholic fatty liver disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：904 / 914

页数：10

共 50 条

[21] Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma
Li, Qinggang
Xing, Hui
Liu, Dan
Li, Hui
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
[22] The impact of body mass index on prognosis in patients with colon carcinoma
Fuchs, Julian
Schellerer, Vera S.
Brunner, Maximilian
Geppert, Carol, I
Gruetzmann, Robert
Weber, Klaus
Merkel, Susanne
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (05) : 1107 - 1117
[23] Analysis of the impact of the body mass index in patients with gastric carcinoma
Nozoe, Tadahiro
Kohno, Mayuko
Iguchi, Tomohiro
Mori, Emiko
Maeda, Takashi
Matsukuma, Akito
Ezaki, Takahiro
SURGERY TODAY, 2012, 42 (10) : 945 - 949
[24] Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
Ollivier-Hourmand, Isabelle
Allaire, Manon
Cervoni, Jean Paul
JOURNAL OF HEPATOLOGY, 2022, 77 (02)
[25] The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ss-catenin signaling
Krug, Sebastian
Mattheis, Laura
Haemmerle, Monika
Rosendahl, Jonas
Kleeff, Joerg
Michl, Patrick
CANCER REPORTS, 2022, 5 (03)
[26] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
Persano, Mara
Rimini, Margherita
Tada, Toshifumi
Suda, Goki
Shimose, Shigeo
Kudo, Masatoshi
Cheon, Jaekyung
Finkelmeier, Fabian
Lim, Ho Yeong
Rimassa, Lorenza
Presa, Jose
Masi, Gianluca
Yoo, Changhoon
Lonardi, Sara
Tovoli, Francesco
Kumada, Takashi
Sakamoto, Naoya
Iwamoto, Hideki
Aoki, Tomoko
Chon, Hong Jae
Himmelsbach, Vera
Pressiani, Tiziana
Kawaguchi, Takumi
Montes, Margarida
Vivaldi, Caterina
Solda, Caterina
Piscaglia, Fabio
Hiraoka, Atsushi
Sho, Takuya
Niizeki, Takashi
Nishida, Naoshi
Steup, Christoph
Iavarone, Massimo
Di Costanzo, Giovanni
Marra, Fabio
Scartozzi, Mario
Tamburini, Emiliano
Cabibbo, Giuseppe
Foschi, Francesco Giuseppe
Silletta, Marianna
Hirooka, Masashi
Kariyama, Kazuya
Tani, Joji
Atsukawa, Masanori
Takaguchi, Koichi
Itobayashi, Ei
Fukunishi, Shinya
Tsuji, Kunihiko
Ishikawa, Toru
Tajiri, Kazuto
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5591 - 5602
[27] Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma
Matsumoto, Hiroaki
Tsuchiya, Kaoru
Nakanishi, Hiroyuki
Hayakawa, Yuka
Yasui, Yutaka
Uchihara, Naoki
Suzuki, Keito
Tanaka, Yuki
Miyamoto, Haruka
Ishido, Shun
Yamada, Michiko
Keitoku, Taisei
Nobusawa, Tsubasa
Higuchi, Mayu
Takaura, Kenta
Tanaka, Shohei
Maeyashiki, Chiaki
Tamaki, Nobuharu
Takahashi, Yuka
Kurosaki, Masayuki
Asahina, Yasuhiro
Okamoto, Ryuichi
Izumi, Namiki
CANCERS, 2022, 14 (14)
[28] Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma
Conticchio, Maria
Inchingolo, Riccardo
Delvecchio, Antonella
Ratti, Francesca
Gelli, Maximiliano
Ferdinando Anelli, Massimiliano
Laurent, Alexis
Vitali, Giulio Cesare
Magistri, Paolo
Assirati, Giacomo
Felli, Emanuele
Wakabayashi, Taiga
Pessaux, Patrick
Piardi, Tullio
di Benedetto, Fabrizio
de'Angelis, Nicola
Briceno, Javier
Rampoldi, Antonio
Adam, Rene
Cherqui, Daniel
Aldrighetti, Luca Antonio
Memeo, Riccardo
WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (01): : 72 - 81
[29] Impact of body mass index in Korean patients with renal cell carcinoma
Sung, Hyun Hwan
Jeon, Seong Soo
Park, Seo Yong
Jeong, Byong Chang
Seo, Seong Il
Lee, Hyun Moo
Choi, Han-Yong
CANCER CAUSES & CONTROL, 2012, 23 (03) : 505 - 511
[30] Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
Hatanaka, Takeshi
Kakizaki, Satoru
Hiraoka, Atsushi
Tada, Toshifumi
Hirooka, Masashi
Kariyama, Kazuya
Tani, Joji
Atsukawa, Masanori
Takaguchi, Koichi
Itobayashi, Ei
Fukunishi, Shinya
Tsuji, Kunihiko
Ishikawa, Toru
Tajiri, Kazuto
Ochi, Hironori
Yasuda, Satoshi
Toyoda, Hidenori
Ogawa, Chikara
Nishimura, Takashi
Shimada, Noritomo
Kawata, Kazuhito
Kosaka, Hisashi
Tanaka, Takaaki
Ohama, Hideko
Nouso, Kazuhiro
Morishita, Asahiro
Tsutsui, Akemi
Nagano, Takuya
Itokawa, Norio
Okubo, Tomomi
Arai, Taeang
Imai, Michitaka
Naganuma, Atsushi
Koizumi, Yohei
Nakamura, Shinichiro
Joko, Kouji
Kaibori, Masaki
Iijima, Hiroko
Hiasa, Yoichi
Kumada, Takashi
HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1150 - 1160

← 1 2 3 4 5 →